FDA Inspection
Patheon Inc.Patheon Inc. – FDA Inspection, Feb 17, 2023
Record Details
This FDA Inspection record concerns Patheon Inc., with an inspection on February 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f5b03d40-f0dc-4c80-890e-6501818956b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1198322
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.165(a)Testing and release for distribution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Patheon Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 22, 2017 | Not classified | Office of Inspections and Investigations | |
| December 9, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Patheon Inc.
- FDA Inspection 1065689 - 2018-09-14
- FDA Inspection 1029053 - 2017-06-22
- FDA Inspection 1002468 - 2016-12-09
- FDA Inspection 976246 - 2016-02-26
- FDA Inspection 878561 - 2014-04-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.